Global Rapid Diagnostics Market - Market Trends, Segmentation, Size and Forecast, Competitive Landscape and other key Analysis

Date : Mar 2021

|

Report ID : 634

|

Category : Medical Devices

|
Report Format:  PDF EXCEL PPT WORD
The Global Rapid Diagnostics Market was valued at US$ 25.9 Billion in 2019 and is expected to reach US$ 47.9 Billion by 2025 growing at a Compounded Annual Growth Rate (CAGR) of 10.81% during the forecast period.

The Market is studied through the below listed segments. This segmentation has been built taking in account the material impact that each of these segments have on the overall ecosystem of the Rapid Diagnostics Market.

BY PRODUCT
• ANALYZERS/
INSTRUMENTS & SOFTWARE
• CONSUMABLES

The CONSUMABLES sub-segment has the largest impact on the Rapid Diagnostics Market when segmented BY PRODUCT with a share of ~73%

BY PRESCRIPTION
• PRESCRIPTION-BASED
POC DIAGNOSTICS
• AT-HOME/OTC-BASED
POC DIAGNOSTICS

The AT-HOME/OTC-BASED
POC DIAGNOSTICS sub-segment has the largest share in the Rapid Diagnostics Market when segmented BY PRESCRIPTION with a share of ~51%

BY APPLICATIONS
• BLOOD GLUCOSE TESTING
• CARDIOMETABOLIC TESTING
• INFECTIOUS DISEASE TESTING
• BLOOD COAGULATION TESTING
• HEMATOLOGY TESTING
• CANCER TESTING
• DRUGS OF ABUSE TESTING
• PREGNANCY AND
FERTILITY/OVULATION TESTING

The largest sub-segment within the Rapid Diagnostics Market when segmented BY APPLICATIONS is BLOOD GLUCOSE TESTING with a share of ~61%

BY END-USERS
• HOSPITALS & CLINICS
• LABORATORIES
• INDIVIDUALS/
HOME HEALTHCARE SETTINGS
• OTHERS

The INFECTIOUS DISEASE TESTING sub-segment has the largest impact on the Rapid Diagnostics Market when segmented BY END-USERS with a share of ~51%

Regional Analysis:
From a geographic segmentation perspective, the report focuses on the regions that have a material and significant effect on the market dynamics. The broad level coverage of the report includes the regions and key countries within the regions of Global, North America, Europe, APAC, MEA

The NORTH AMERICA Region has the largest share in the Rapid Diagnostics Market from a Geographic Analysis point of view with a share of ~38%

Competitive Landscape:
The Rapid Diagnostics Market is fairly fragmented. While the key companies continue to drive innovation and, in most cases, adopt digital transformations, the overall competitive ecosystem is dominated by Market leaders as well as emerging players with niche offerings.

This Rapid Diagnostics Market report profiles some of the key market players while reviewing significant market developments and strategies adopted by them.
While looking at Organic and Inorganic strategies separately, the report studies not only outlook based (short-mid-long term), but also strategy based (strategic vs operational) market activity.

Key Companies profiled in this report include:
• ABBOTT
• SIEMENS HEALTHINEERS
• BD
• QUIDEL
• DANAHER
• F HOFFMANN-LA ROCHE
• LIFESCAN
• ASCENSIA DIABETES CARE HOLDINGS
• ABAXIS
• ABINGDON HEALTH
• ACON LABORATORIES
• AGAMATRIX
• ARBOR VITA
• ASSURE TECH
• AUTOBIO
• BEIJING WANTAI BIOPHARM
• BIOMERICA
• BIOM•RIEUX
• BIOPANDA REAGENTS
• CHEMBIO DIAGNOSTIC SYSTEMS
• CELLEX
• CLINICAL REFERENCE LABORATORY
• CTK BIOTECH
• EKF DIAGNOSTICS
• EXACT SCIENCES
• HANGZHOU ALLTEST BIOTECH
• HANGZHOU BIOTEST BIOTECH
• HEALGEN SCIENTIFIC
• INSTRUMENTATION LABORATORY
• MEGNA HEALTH
• MERIDIAN BIOSCIENCE
• MP BIOMEDICALS
• NOWDIAGNOSTICS
• SALOFA OY
• SEKISUI DIAGNOSTICS
• SEASUN BIOMATERIALS
• SINOCARE
• SURESCREEN DIAGNOSTICS
• SYSMEX
• SWISS PRECISION DIAGNOSTICS

While most of the Key Profiles are of Market Leaders, the profiling involves coverage of the market ecosystem. Based on the Market Strategy that a client is exploring, the Competitive Landscape is customized to make the CI data more actionable and relevant for the strategy execution.
Company profiles usually include:
• Company Overview
• Performance Overview
• Products / Services Overview
• Recent Developments

The Covid19 pandemic has transformed the market landscape. The second-wave in 2021 has highlighted the importance of Business Resilience and is putting lot of impetus on the business strategies involving bottom-line management like vendor-management, cost-optimization, etc., This report covers the aftermath of the Covid19 catastrophe and the key trends that need to be incorporate in Business plans.

Report Customization:
Our dynamic and proprietary data-mining technology has given us the flexibility to maintain both precision and speed while delivering exclusive and custom insights to our clients.
We conduct customization of the Research data on all key fronts • Regional, Segment, Competitive landscape level. For every report-purchase, we offer 25 free analyst-hours to address critical factor sought in the Research activity

Report Scope:
From a business-objective perspective, the Report details out the key take-aways necessary to formulate business strategies like:
• New product launch
• New client acquisition
• New opportunity mapping (market level and geography level)
• Competitive benchmarking
• Cost optimization strategies
• Inorganic expansion plans
......and more.
Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency


Chapter 2. Executive Summary
2.1 Rapid Diagnostics Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Rapid Diagnostics Market Business Segmentation
2.5 Rapid Diagnostics Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics


Chapter 3. Strategic Analysis
3.1 Rapid Diagnostics Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Rapid Diagnostics Market Digital Transformation


Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News


Chapter 5. Market Segmentation
The Rapid Diagnostics Market has been analysed to include the below segmentation:

BY PRODUCT
• ANALYZERS/
INSTRUMENTS & SOFTWARE
• CONSUMABLES

BY PRESCRIPTION
• PRESCRIPTION-BASED
POC DIAGNOSTICS
• AT-HOME/OTC-BASED
POC DIAGNOSTICS

BY APPLICATIONS
• BLOOD GLUCOSE TESTING
• CARDIOMETABOLIC TESTING
• INFECTIOUS DISEASE TESTING
• BLOOD COAGULATION TESTING
• HEMATOLOGY TESTING
• CANCER TESTING
• DRUGS OF ABUSE TESTING
• PREGNANCY AND
FERTILITY/OVULATION TESTING

BY END-USERS
• HOSPITALS & CLINICS
• LABORATORIES
• INDIVIDUALS/
HOME HEALTHCARE SETTINGS
• OTHERS
Chapter 5A. Regional Segmentation
The Rapid Diagnostics Market has been analysed by studying the following regions:

North America
• BY PRODUCT
• BY PRESCRIPTION
• BY APPLICATIONS
• BY END-USERS

Europe
• BY PRODUCT
• BY PRESCRIPTION
• BY APPLICATIONS
• BY END-USERS

APAC
• BY PRODUCT
• BY PRESCRIPTION
• BY APPLICATIONS
• BY END-USERS

LatAm
• BY PRODUCT
• BY PRESCRIPTION
• BY APPLICATIONS
• BY END-USERS

MEA
• BY PRODUCT
• BY PRESCRIPTION
• BY APPLICATIONS
• BY END-USERS

**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;

Chapter 6. Market Use case studies

Chapter 7. KOL Recommendations

Chapter 8. Investment Landscape
8.1 Rapid Diagnostics Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity


Chapter 9. Rapid Diagnostics Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies


Chapter 10. Key Company Profiles
*The Rapid Diagnostics Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments

Key Companies profiled in this report include:
• ABBOTT
• SIEMENS HEALTHINEERS
• BD
• QUIDEL
• DANAHER
• F HOFFMANN-LA ROCHE
• LIFESCAN
• ASCENSIA DIABETES CARE HOLDINGS
• ABAXIS
• ABINGDON HEALTH
• ACON LABORATORIES
• AGAMATRIX
• ARBOR VITA
• ASSURE TECH
• AUTOBIO
• BEIJING WANTAI BIOPHARM
• BIOMERICA
• BIOM•RIEUX
• BIOPANDA REAGENTS
• CHEMBIO DIAGNOSTIC SYSTEMS
• CELLEX
• CLINICAL REFERENCE LABORATORY
• CTK BIOTECH
• EKF DIAGNOSTICS
• EXACT SCIENCES
• HANGZHOU ALLTEST BIOTECH
• HANGZHOU BIOTEST BIOTECH
• HEALGEN SCIENTIFIC
• INSTRUMENTATION LABORATORY
• MEGNA HEALTH
• MERIDIAN BIOSCIENCE
• MP BIOMEDICALS
• NOWDIAGNOSTICS
• SALOFA OY
• SEKISUI DIAGNOSTICS
• SEASUN BIOMATERIALS
• SINOCARE
• SURESCREEN DIAGNOSTICS
• SYSMEX
• SWISS PRECISION DIAGNOSTICS

Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us

Choose License
Buy Now
Why Choose AllTheResearch?
  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on “Quadrant Positioning” of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports. Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.


Quick Inquiry
Follow Us
Choose License
Buy Now